HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Efficacy of intravenous administration of itraconazole on fungal infections in immunocompromised patients with hematological diseases].

AbstractOBJECTIVE:
To investigate the efficacy of intravenous administration of itraconazole on fungal infections in immunocompromised patients with hematological diseases according to stratified diagnoses.
METHODS:
Twenty-five patients with hematological diseases who were diagnosed according to the criteria of European Organization for Research and Treatment of Cancer (EORTC), including 6 cases with confirmed diagnosis diagnosis, 12 cases with clinical diagnosis, and 7 cases with recommended diagnosis, underwent intravenous injection of itraconazole 125 approximately 200 mg bid for 2 days and then qd for at most 2 weeks and then oral administration of itraconazole 0.4 g/day for at most 2 weeks, and then the repeated regimen with a course of treatment of 1 approximately 3 months from 2002 to 2004. Eighteen cases were diagnosed with lung infection, 1 case with sinuses and trachea infection, and the infection sites were not documented for other 7 cases. The clinical results were analyzed.
RESULTS:
The effective rates of the patients with confirmed diagnosis, with clinical diagnosis, and with recommended diagnosis were 66.7% (4/6), 83.3% (10/12), and 14.3% (1/7) respectively. The effective rates of the patients with major imaging signs and those with secondary imaging signs were 90.0% (9/10) and 97.1% (4/7). There was a significant difference between the curative effects of the patients with confirmed diagnosis and those with recommended diagnosis (P = 0.006).
CONCLUSION:
Fungal infections in immunocompromised patients with hematological diseases can be successfully treated with intravenous administration of itraconazole.
AuthorsJing-zhi Wang, Xiao-jun Huang, Kai-yan Liu, Dai-hong Liu, Huan Chen, Lan-ping Xu, Jin Lu, Yao-chen Zhang, Wei Han, Dao-pei Lu
JournalZhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi) Vol. 85 Issue 21 Pg. 1481-3 (Jun 8 2005) ISSN: 0376-2491 [Print] China
PMID16061027 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antifungal Agents
  • Itraconazole
Topics
  • Adolescent
  • Adult
  • Antifungal Agents (therapeutic use)
  • Candidiasis (drug therapy, etiology)
  • Child
  • Female
  • Hematologic Diseases (complications, immunology)
  • Humans
  • Immunocompromised Host
  • Injections, Intravenous
  • Itraconazole (therapeutic use)
  • Male
  • Middle Aged
  • Mycoses (drug therapy, etiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: